Synaptogenix Stock Annual Yield
| SNPX Stock | USD 2.72 0.01 0.37% |
Synaptogenix fundamentals help investors to digest information that contributes to Synaptogenix's financial success or failures. It also enables traders to predict the movement of Synaptogenix Stock. The fundamental analysis module provides a way to measure Synaptogenix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Synaptogenix stock.
Synaptogenix | Annual Yield |
Synaptogenix Company Annual Yield Analysis
Synaptogenix's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Synaptogenix Annual Yield Driver Correlations
Understanding the fundamental principles of building solid financial models for Synaptogenix is extremely important. It helps to project a fair market value of Synaptogenix Stock properly, considering its historical fundamentals such as Annual Yield. Since Synaptogenix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Synaptogenix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Synaptogenix's interrelated accounts and indicators.
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
Synaptogenix Dividend Yield
Dividend Yield |
|
In accordance with the recently published financial statements, Synaptogenix has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Synaptogenix ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Synaptogenix's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Synaptogenix's managers, analysts, and investors.Environmental | Governance | Social |
Synaptogenix Fundamentals
| Return On Equity | -0.075 | ||||
| Return On Asset | -0.14 | ||||
| Current Valuation | (18.07 M) | ||||
| Shares Outstanding | 1.36 M | ||||
| Shares Owned By Insiders | 1.94 % | ||||
| Shares Owned By Institutions | 0.29 % | ||||
| Number Of Shares Shorted | 5.46 K | ||||
| Price To Book | 0.29 X | ||||
| EBITDA | (8.31 M) | ||||
| Net Income | (6.04 M) | ||||
| Cash And Equivalents | 28.75 M | ||||
| Cash Per Share | 4.20 X | ||||
| Total Debt | 5.53 M | ||||
| Current Ratio | 47.22 X | ||||
| Book Value Per Share | 14.99 X | ||||
| Cash Flow From Operations | (5.17 M) | ||||
| Short Ratio | 0.17 X | ||||
| Earnings Per Share | 10.27 X | ||||
| Target Price | 14.0 | ||||
| Beta | 1.43 | ||||
| Market Capitalization | 4.07 M | ||||
| Total Asset | 31.11 M | ||||
| Retained Earnings | (33.61 M) | ||||
| Working Capital | 26.26 M | ||||
| Net Asset | 31.11 M |
About Synaptogenix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Synaptogenix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Synaptogenix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Synaptogenix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Synaptogenix Stock Analysis
When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.